Silver Explorer Records Profit While Waiting To Open Plant
Source: Streetwise Reports  (12/1/22)
MAG Silver Corp. is waiting for the OK to open its processing plant in Mexico, but is already generating a profit with the material it is mining. More >

Equipment Dealer Posts Record 88% Increase in Q3 EPS
Source: Streetwise Reports  (12/1/22)
Shares of Titan Machinery Inc. traded 26% higher yesterday to a new 52-week high after the company reported Q3/23 financial results, highlighting a 47.3% YOY increase in revenue. The firm additionally raised its full-year revenue and earnings estimates. More >

Target Price Boosted on Canadian Pharma Co.
Source: Dr. Andre Uddin  (11/30/22)
This company, undergoing a business model shift, is doing well and remains Buy rated despite a weaker-than-expected Q3/22, noted a Research Capital Corp. report. More >

More Drill Results Expand Areas of Gold at Idaho Project
Source: Geordie Mark  (11/30/22)
These new data, from three zones at the property, bode well for growing the existing resource there, noted a Haywood Securities report. More >

Gold Miner Strikes 19.1m of 43.3 g/t Au at Alaska Property
Source: Streetwise Reports  (11/30/22)
HighGold Mining Inc. shares traded 14% higher after the company reported that it intersected 120m of 18.76 g/t gold at its Johnson Tract Deposit in Southcentral Alaska. More >

Biopharma Co. Now at a Bargain Price, Analyst Says
Source: Dr. Andrew Uddin   (11/29/22)
Recent share price weakness and a catalyst-rich next six months are good news for investors, noted a Research Capital Corp. report. More >

Mining Co. Hits Record Gold, Silver Grades at B.C. Property
Source: Stuart McDougall  (11/29/22)
The newly reported drill results also extended the mineralization present at the primary exploration target, noted a Research Capital Corp. report. More >

Little Drone Co. Could Have Big Impact
Source: Streetwise Reports  (11/29/22)
Volatus Aerospace Corp. could be a company to watch in the fast-growing drone aviation market. More >

Major Contract and Faster Commercialization for Chemicals Co.
Source: Penny Queen  (11/29/22)
Since hitting the market on November 10, 2022, ASP Isotopes has been busy and has now announced a US$675 million-dollar contract. Expert Penny Queen shares this news and reviews why she still believes this company is worthwhile. More >

Expert Says, 'Buy Selectively in This Vulnerable Market'
Source: Adrian Day  (11/29/22)
Today, expert Adrian Day sends a revised Current Positions table, updating dividends paid and current recommendations. Prices are as of early afternoon yesterday. More >

The Economy May Not Look Good but Oil and Energy Transport Stocks Do
Source: Ron Struthers  (11/29/22)
Expert Ron Struthers believes consumers are on an unsustainable path of wracking up credit card debt, and it is only a matter of when the economy buckles, meanwhile big profits are being made by tanker companies and oil and gas/energy transmission companies as supplies continue to tighten. More >

Software Firm's Q2 FY23 Results Reflect Healthy Growth
Source: Amr Ezzat   (11/28/22)
This company serving the oil and gas industry grew revenue 14% over the last 12 months and is expected to continue the trend, noted an Echelon Capital Markets report. More >

Co. To Boost Natural Gas Production After Pipeline is Built
Source: Bill Newman  (11/28/22)
The Canadian company has already secured two contracts for three-quarters of the capacity of this new pipeline in Colombia, noted a Research Capital Corp. report. More >

Copper Co. Potentially Expands Deposit in Colombia
Source: Streetwise Reports  (11/28/22)
A soil geochemical anomaly could significantly expand the footprint and potential size of the deposit at Libero Copper and Gold Corp.'s Mocoa project in Putumayo, Colombia. More >

We're at the Home Stretch
Source: Michael Ballanger  (11/28/22)
With only 33 days left in the fiscal year 2022, expert Michael Ballanger reviews where he believes the markets are heading. More >

Expert Says Health Tech Co. Still in Good Spot To Buy
Source: Clive Maund  (11/28/22)
Technical analyst Clive Maund reviews the 1-year chart for Reliq Health Technologies to tell you whether he believes it is a Buy. More >

Biopharma Co. Trades to New 52-Week High
Source: Streetwise Reports  (11/28/22)
Shares of Axsome Therapeutics Inc. traded to a new 52-week high after the company reported its AXS-05 successfully met both the primary and key secondary endpoints
in the Phase 3 ACCORD Alzheimer's disease agitation trial. More >

Green Co. Taking Steps To Start Construction of Ecuador Plant
Source: Streetwise Reports  (11/25/22)
BacTech Environmental Corp. is completing an engineering report needed to start construction of its bioleaching plant in Tenguel, Ecuador. More >

Gold Co. 'Is in Good Shape Financially' Despite Shortfall
Source: Ryan Walker  (11/24/22)
The company aims to achieve record production in Q4/22 to recover from the hit in Q3/22, noted an Echelon Capital Markets report. More >

Co. Among Top 10 Gold Producers Reports In Line Q3/22 Results
Source: Geordie Mark   (11/23/22)
The outlook for full-year 2022 production is positive, and growth is expected, noted a Haywood Securities report. More >

Post Breakout Reaction Provides Another Buying Opportunity
Source: Clive Maund  (11/23/22)
With the breakdown of the U.S. dollar, expert Clive Maund reviews charts for gold, copper, and palladium to tell you where he believes the metals are headed and which he thinks you should buy. More >

Pharma Co. Gains Approval for SARS-CoV-2 Drug
Source: Streetwise Reports  (11/23/22)
Shares of Japanese pharmaceutical firm Shionogi & Co. Ltd. traded nearly 13% higher yesterday after the company reported it received emergency regulatory approval from Japan's Ministry of Health, Labor, and Welfare for its Xocova® (ensitrelvir fumaric acid) tablets for use in treating SARS-CoV-2 infection. More >

Mining Royalty Co. Posts Best Cash Margins to Date
Source: Kerry Smith  (11/22/22)
Also, operating cash flow was a beat during this strong quarter for the Quebec-based firm, noted a Haywood Securities report. More >

Life Sciences Co. Exceeds Expectations in Q3/22
Source: Dr. Andre Uddin  (11/22/22)
During the quarter, the Canadian specialty biopharma performed well and maintained a healthy balance sheet, such that it raised revenue guidance for this year, noted a Research Capital Corp. report. More >

Q4/22 Catalysts Could Boost Undervalued Biopharma Stock
Source: Dr. Yale Jen  (11/22/22)
The year's final quarter is significant for this U.S.-based firm given the trio of significant clinical achievements in its sight, noted a Laidlaw & Co. report. More >